nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—HDAC3—islet of Langerhans—pancreatic cancer	0.0091	0.109	CbGeAlD
Vorinostat—HDAC1—islet of Langerhans—pancreatic cancer	0.00834	0.0995	CbGeAlD
Vorinostat—HDAC9—islet of Langerhans—pancreatic cancer	0.0082	0.0978	CbGeAlD
Vorinostat—HDAC8—digestive system—pancreatic cancer	0.00737	0.0879	CbGeAlD
Vorinostat—HDAC11—digestive system—pancreatic cancer	0.00643	0.0767	CbGeAlD
Vorinostat—HDAC3—pancreas—pancreatic cancer	0.0064	0.0763	CbGeAlD
Vorinostat—NCOR1—digestive system—pancreatic cancer	0.00623	0.0744	CbGeAlD
Vorinostat—HDAC1—pancreas—pancreatic cancer	0.00586	0.0699	CbGeAlD
Vorinostat—HDAC9—pancreas—pancreatic cancer	0.00576	0.0688	CbGeAlD
Vorinostat—HDAC3—digestive system—pancreatic cancer	0.00546	0.0652	CbGeAlD
Vorinostat—HDAC1—digestive system—pancreatic cancer	0.005	0.0597	CbGeAlD
Vorinostat—HDAC2—Topotecan—Irinotecan—pancreatic cancer	0.00496	0.598	CbGdCrCtD
Vorinostat—HDAC2—islet of Langerhans—pancreatic cancer	0.00419	0.05	CbGeAlD
Vorinostat—HDAC2—Gefitinib—Erlotinib—pancreatic cancer	0.00334	0.402	CbGdCrCtD
Vorinostat—HDAC2—pancreas—pancreatic cancer	0.00295	0.0352	CbGeAlD
Vorinostat—HDAC2—digestive system—pancreatic cancer	0.00252	0.03	CbGeAlD
Vorinostat—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000876	0.00276	CcSEcCtD
Vorinostat—Syncope—Erlotinib—pancreatic cancer	0.000874	0.00275	CcSEcCtD
Vorinostat—Myocardial infarction—Irinotecan—pancreatic cancer	0.000872	0.00274	CcSEcCtD
Vorinostat—Chills—Sunitinib—pancreatic cancer	0.000869	0.00274	CcSEcCtD
Vorinostat—Neoplasm malignant—Epirubicin—pancreatic cancer	0.000868	0.00273	CcSEcCtD
Vorinostat—Abscess—Doxorubicin—pancreatic cancer	0.000867	0.00273	CcSEcCtD
Vorinostat—Cough—Tamoxifen—pancreatic cancer	0.000859	0.0027	CcSEcCtD
Vorinostat—Loss of consciousness—Erlotinib—pancreatic cancer	0.000856	0.00269	CcSEcCtD
Vorinostat—Alopecia—Sunitinib—pancreatic cancer	0.000856	0.00269	CcSEcCtD
Vorinostat—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.000854	0.00269	CcSEcCtD
Vorinostat—Cough—Erlotinib—pancreatic cancer	0.00085	0.00268	CcSEcCtD
Vorinostat—Myocardial infarction—Gemcitabine—pancreatic cancer	0.000849	0.00267	CcSEcCtD
Vorinostat—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.000839	0.00264	CcSEcCtD
Vorinostat—Chest pain—Tamoxifen—pancreatic cancer	0.000838	0.00264	CcSEcCtD
Vorinostat—Myocardial infarction—Fluorouracil—pancreatic cancer	0.000835	0.00263	CcSEcCtD
Vorinostat—Chest pain—Erlotinib—pancreatic cancer	0.00083	0.00261	CcSEcCtD
Vorinostat—Dysgeusia—Sunitinib—pancreatic cancer	0.000826	0.0026	CcSEcCtD
Vorinostat—Dry mouth—Tamoxifen—pancreatic cancer	0.00082	0.00258	CcSEcCtD
Vorinostat—Lethargy—Docetaxel—pancreatic cancer	0.000814	0.00256	CcSEcCtD
Vorinostat—Muscle spasms—Sunitinib—pancreatic cancer	0.000811	0.00255	CcSEcCtD
Vorinostat—Neoplasm malignant—Doxorubicin—pancreatic cancer	0.000803	0.00253	CcSEcCtD
Vorinostat—Infection—Tamoxifen—pancreatic cancer	0.000798	0.00251	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Docetaxel—pancreatic cancer	0.000798	0.00251	CcSEcCtD
Vorinostat—Infection—Erlotinib—pancreatic cancer	0.00079	0.00249	CcSEcCtD
Vorinostat—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000787	0.00248	CcSEcCtD
Vorinostat—Shock—Erlotinib—pancreatic cancer	0.000782	0.00246	CcSEcCtD
Vorinostat—Anaemia—Sunitinib—pancreatic cancer	0.00078	0.00245	CcSEcCtD
Vorinostat—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000779	0.00245	CcSEcCtD
Vorinostat—Angioedema—Sunitinib—pancreatic cancer	0.000771	0.00242	CcSEcCtD
Vorinostat—Anorexia—Tamoxifen—pancreatic cancer	0.000766	0.00241	CcSEcCtD
Vorinostat—Oedema peripheral—Gemcitabine—pancreatic cancer	0.000766	0.00241	CcSEcCtD
Vorinostat—Anorexia—Erlotinib—pancreatic cancer	0.000758	0.00238	CcSEcCtD
Vorinostat—Leukopenia—Sunitinib—pancreatic cancer	0.000755	0.00238	CcSEcCtD
Vorinostat—Dehydration—Docetaxel—pancreatic cancer	0.000742	0.00233	CcSEcCtD
Vorinostat—Pulmonary embolism—Epirubicin—pancreatic cancer	0.000741	0.00233	CcSEcCtD
Vorinostat—Cough—Sunitinib—pancreatic cancer	0.000736	0.00232	CcSEcCtD
Vorinostat—Chest pain—Sunitinib—pancreatic cancer	0.000718	0.00226	CcSEcCtD
Vorinostat—Chills—Irinotecan—pancreatic cancer	0.000716	0.00225	CcSEcCtD
Vorinostat—Alopecia—Irinotecan—pancreatic cancer	0.000705	0.00222	CcSEcCtD
Vorinostat—Dry mouth—Sunitinib—pancreatic cancer	0.000702	0.00221	CcSEcCtD
Vorinostat—Decreased appetite—Tamoxifen—pancreatic cancer	0.000699	0.0022	CcSEcCtD
Vorinostat—Chills—Gemcitabine—pancreatic cancer	0.000698	0.00219	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000694	0.00218	CcSEcCtD
Vorinostat—Fatigue—Tamoxifen—pancreatic cancer	0.000693	0.00218	CcSEcCtD
Vorinostat—Decreased appetite—Erlotinib—pancreatic cancer	0.000691	0.00217	CcSEcCtD
Vorinostat—Constipation—Tamoxifen—pancreatic cancer	0.000687	0.00216	CcSEcCtD
Vorinostat—Alopecia—Gemcitabine—pancreatic cancer	0.000687	0.00216	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000687	0.00216	CcSEcCtD
Vorinostat—Pulmonary embolism—Doxorubicin—pancreatic cancer	0.000686	0.00216	CcSEcCtD
Vorinostat—Fatigue—Erlotinib—pancreatic cancer	0.000686	0.00216	CcSEcCtD
Vorinostat—Infection—Sunitinib—pancreatic cancer	0.000684	0.00215	CcSEcCtD
Vorinostat—Constipation—Erlotinib—pancreatic cancer	0.00068	0.00214	CcSEcCtD
Vorinostat—Shock—Sunitinib—pancreatic cancer	0.000677	0.00213	CcSEcCtD
Vorinostat—Alopecia—Fluorouracil—pancreatic cancer	0.000675	0.00213	CcSEcCtD
Vorinostat—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000674	0.00212	CcSEcCtD
Vorinostat—Muscle spasms—Irinotecan—pancreatic cancer	0.000668	0.0021	CcSEcCtD
Vorinostat—Anorexia—Sunitinib—pancreatic cancer	0.000656	0.00206	CcSEcCtD
Vorinostat—Pancytopenia—Docetaxel—pancreatic cancer	0.000655	0.00206	CcSEcCtD
Vorinostat—Neutropenia—Docetaxel—pancreatic cancer	0.000645	0.00203	CcSEcCtD
Vorinostat—Sepsis—Epirubicin—pancreatic cancer	0.000643	0.00202	CcSEcCtD
Vorinostat—Anaemia—Irinotecan—pancreatic cancer	0.000642	0.00202	CcSEcCtD
Vorinostat—Body temperature increased—Erlotinib—pancreatic cancer	0.000629	0.00198	CcSEcCtD
Vorinostat—Anaemia—Gemcitabine—pancreatic cancer	0.000626	0.00197	CcSEcCtD
Vorinostat—Weight decreased—Docetaxel—pancreatic cancer	0.000624	0.00196	CcSEcCtD
Vorinostat—Syncope—Irinotecan—pancreatic cancer	0.000623	0.00196	CcSEcCtD
Vorinostat—Leukopenia—Irinotecan—pancreatic cancer	0.000622	0.00196	CcSEcCtD
Vorinostat—Anaemia—Fluorouracil—pancreatic cancer	0.000615	0.00194	CcSEcCtD
Vorinostat—Loss of consciousness—Irinotecan—pancreatic cancer	0.000611	0.00192	CcSEcCtD
Vorinostat—Cough—Irinotecan—pancreatic cancer	0.000606	0.00191	CcSEcCtD
Vorinostat—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000606	0.00191	CcSEcCtD
Vorinostat—Leukopenia—Gemcitabine—pancreatic cancer	0.000606	0.00191	CcSEcCtD
Vorinostat—Myocardial infarction—Docetaxel—pancreatic cancer	0.000602	0.0019	CcSEcCtD
Vorinostat—Decreased appetite—Sunitinib—pancreatic cancer	0.000598	0.00188	CcSEcCtD
Vorinostat—Leukopenia—Fluorouracil—pancreatic cancer	0.000596	0.00187	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—pancreatic cancer	0.000595	0.00187	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000594	0.00187	CcSEcCtD
Vorinostat—Fatigue—Sunitinib—pancreatic cancer	0.000594	0.00187	CcSEcCtD
Vorinostat—Cough—Gemcitabine—pancreatic cancer	0.000591	0.00186	CcSEcCtD
Vorinostat—Constipation—Sunitinib—pancreatic cancer	0.000589	0.00185	CcSEcCtD
Vorinostat—Asthenia—Tamoxifen—pancreatic cancer	0.000577	0.00181	CcSEcCtD
Vorinostat—Chest pain—Gemcitabine—pancreatic cancer	0.000576	0.00181	CcSEcCtD
Vorinostat—Asthenia—Erlotinib—pancreatic cancer	0.000571	0.0018	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Epirubicin—pancreatic cancer	0.00057	0.00179	CcSEcCtD
Vorinostat—Pruritus—Tamoxifen—pancreatic cancer	0.000569	0.00179	CcSEcCtD
Vorinostat—Chest pain—Fluorouracil—pancreatic cancer	0.000567	0.00178	CcSEcCtD
Vorinostat—Infection—Irinotecan—pancreatic cancer	0.000563	0.00177	CcSEcCtD
Vorinostat—Pruritus—Erlotinib—pancreatic cancer	0.000563	0.00177	CcSEcCtD
Vorinostat—Shock—Irinotecan—pancreatic cancer	0.000558	0.00176	CcSEcCtD
Vorinostat—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000555	0.00175	CcSEcCtD
Vorinostat—Diarrhoea—Tamoxifen—pancreatic cancer	0.00055	0.00173	CcSEcCtD
Vorinostat—Lethargy—Epirubicin—pancreatic cancer	0.000549	0.00173	CcSEcCtD
Vorinostat—Infection—Gemcitabine—pancreatic cancer	0.000549	0.00173	CcSEcCtD
Vorinostat—Body temperature increased—Sunitinib—pancreatic cancer	0.000544	0.00171	CcSEcCtD
Vorinostat—Diarrhoea—Erlotinib—pancreatic cancer	0.000544	0.00171	CcSEcCtD
Vorinostat—Oedema peripheral—Docetaxel—pancreatic cancer	0.000544	0.00171	CcSEcCtD
Vorinostat—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000541	0.0017	CcSEcCtD
Vorinostat—Anorexia—Irinotecan—pancreatic cancer	0.000541	0.0017	CcSEcCtD
Vorinostat—Infection—Fluorouracil—pancreatic cancer	0.00054	0.0017	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Epirubicin—pancreatic cancer	0.000538	0.00169	CcSEcCtD
Vorinostat—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000532	0.00167	CcSEcCtD
Vorinostat—Dizziness—Tamoxifen—pancreatic cancer	0.000531	0.00167	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—pancreatic cancer	0.000527	0.00166	CcSEcCtD
Vorinostat—Anorexia—Gemcitabine—pancreatic cancer	0.000527	0.00166	CcSEcCtD
Vorinostat—Dizziness—Erlotinib—pancreatic cancer	0.000526	0.00165	CcSEcCtD
Vorinostat—Anorexia—Fluorouracil—pancreatic cancer	0.000518	0.00163	CcSEcCtD
Vorinostat—Vomiting—Tamoxifen—pancreatic cancer	0.000511	0.00161	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—pancreatic cancer	0.000508	0.0016	CcSEcCtD
Vorinostat—Vomiting—Erlotinib—pancreatic cancer	0.000506	0.00159	CcSEcCtD
Vorinostat—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000504	0.00159	CcSEcCtD
Vorinostat—Headache—Tamoxifen—pancreatic cancer	0.000504	0.00158	CcSEcCtD
Vorinostat—Dehydration—Epirubicin—pancreatic cancer	0.0005	0.00157	CcSEcCtD
Vorinostat—Headache—Erlotinib—pancreatic cancer	0.000498	0.00157	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000498	0.00157	CcSEcCtD
Vorinostat—Chills—Docetaxel—pancreatic cancer	0.000495	0.00156	CcSEcCtD
Vorinostat—Asthenia—Sunitinib—pancreatic cancer	0.000494	0.00155	CcSEcCtD
Vorinostat—Decreased appetite—Irinotecan—pancreatic cancer	0.000493	0.00155	CcSEcCtD
Vorinostat—Hypokalaemia—Epirubicin—pancreatic cancer	0.00049	0.00154	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.00049	0.00154	CcSEcCtD
Vorinostat—Fatigue—Irinotecan—pancreatic cancer	0.000489	0.00154	CcSEcCtD
Vorinostat—Alopecia—Docetaxel—pancreatic cancer	0.000488	0.00153	CcSEcCtD
Vorinostat—Pruritus—Sunitinib—pancreatic cancer	0.000487	0.00153	CcSEcCtD
Vorinostat—Constipation—Irinotecan—pancreatic cancer	0.000485	0.00153	CcSEcCtD
Vorinostat—Decreased appetite—Gemcitabine—pancreatic cancer	0.00048	0.00151	CcSEcCtD
Vorinostat—Nausea—Tamoxifen—pancreatic cancer	0.000477	0.0015	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000477	0.0015	CcSEcCtD
Vorinostat—Fatigue—Gemcitabine—pancreatic cancer	0.000476	0.0015	CcSEcCtD
Vorinostat—Constipation—Gemcitabine—pancreatic cancer	0.000472	0.00149	CcSEcCtD
Vorinostat—Nausea—Erlotinib—pancreatic cancer	0.000472	0.00149	CcSEcCtD
Vorinostat—Decreased appetite—Fluorouracil—pancreatic cancer	0.000472	0.00149	CcSEcCtD
Vorinostat—Diarrhoea—Sunitinib—pancreatic cancer	0.000471	0.00148	CcSEcCtD
Vorinostat—Dysgeusia—Docetaxel—pancreatic cancer	0.00047	0.00148	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000469	0.00148	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000466	0.00147	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—pancreatic cancer	0.000463	0.00146	CcSEcCtD
Vorinostat—Muscle spasms—Docetaxel—pancreatic cancer	0.000462	0.00145	CcSEcCtD
Vorinostat—Dizziness—Sunitinib—pancreatic cancer	0.000455	0.00143	CcSEcCtD
Vorinostat—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000453	0.00143	CcSEcCtD
Vorinostat—Body temperature increased—Irinotecan—pancreatic cancer	0.000448	0.00141	CcSEcCtD
Vorinostat—Anaemia—Docetaxel—pancreatic cancer	0.000444	0.0014	CcSEcCtD
Vorinostat—Pancytopenia—Epirubicin—pancreatic cancer	0.000442	0.00139	CcSEcCtD
Vorinostat—Vomiting—Sunitinib—pancreatic cancer	0.000438	0.00138	CcSEcCtD
Vorinostat—Body temperature increased—Gemcitabine—pancreatic cancer	0.000437	0.00137	CcSEcCtD
Vorinostat—Neutropenia—Epirubicin—pancreatic cancer	0.000435	0.00137	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000432	0.00136	CcSEcCtD
Vorinostat—Headache—Sunitinib—pancreatic cancer	0.000431	0.00136	CcSEcCtD
Vorinostat—Syncope—Docetaxel—pancreatic cancer	0.000431	0.00136	CcSEcCtD
Vorinostat—Leukopenia—Docetaxel—pancreatic cancer	0.00043	0.00135	CcSEcCtD
Vorinostat—Body temperature increased—Fluorouracil—pancreatic cancer	0.000429	0.00135	CcSEcCtD
Vorinostat—Loss of consciousness—Docetaxel—pancreatic cancer	0.000422	0.00133	CcSEcCtD
Vorinostat—Weight decreased—Epirubicin—pancreatic cancer	0.000421	0.00132	CcSEcCtD
Vorinostat—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000419	0.00132	CcSEcCtD
Vorinostat—Cough—Docetaxel—pancreatic cancer	0.000419	0.00132	CcSEcCtD
Vorinostat—Chest pain—Docetaxel—pancreatic cancer	0.000409	0.00129	CcSEcCtD
Vorinostat—Nausea—Sunitinib—pancreatic cancer	0.000409	0.00129	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—pancreatic cancer	0.000409	0.00129	CcSEcCtD
Vorinostat—Asthenia—Irinotecan—pancreatic cancer	0.000407	0.00128	CcSEcCtD
Vorinostat—Neutropenia—Doxorubicin—pancreatic cancer	0.000402	0.00127	CcSEcCtD
Vorinostat—Dry mouth—Docetaxel—pancreatic cancer	0.0004	0.00126	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.0004	0.00126	CcSEcCtD
Vorinostat—Asthenia—Gemcitabine—pancreatic cancer	0.000396	0.00125	CcSEcCtD
Vorinostat—Pruritus—Gemcitabine—pancreatic cancer	0.000391	0.00123	CcSEcCtD
Vorinostat—Infection—Docetaxel—pancreatic cancer	0.000389	0.00123	CcSEcCtD
Vorinostat—Weight decreased—Doxorubicin—pancreatic cancer	0.000389	0.00122	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000388	0.00122	CcSEcCtD
Vorinostat—Diarrhoea—Irinotecan—pancreatic cancer	0.000388	0.00122	CcSEcCtD
Vorinostat—Shock—Docetaxel—pancreatic cancer	0.000386	0.00121	CcSEcCtD
Vorinostat—Pruritus—Fluorouracil—pancreatic cancer	0.000384	0.00121	CcSEcCtD
Vorinostat—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000384	0.00121	CcSEcCtD
Vorinostat—Diarrhoea—Gemcitabine—pancreatic cancer	0.000378	0.00119	CcSEcCtD
Vorinostat—Dizziness—Irinotecan—pancreatic cancer	0.000375	0.00118	CcSEcCtD
Vorinostat—Anorexia—Docetaxel—pancreatic cancer	0.000374	0.00118	CcSEcCtD
Vorinostat—Diarrhoea—Fluorouracil—pancreatic cancer	0.000372	0.00117	CcSEcCtD
Vorinostat—Oedema peripheral—Epirubicin—pancreatic cancer	0.000367	0.00115	CcSEcCtD
Vorinostat—Vomiting—Irinotecan—pancreatic cancer	0.000361	0.00113	CcSEcCtD
Vorinostat—Dizziness—Fluorouracil—pancreatic cancer	0.000359	0.00113	CcSEcCtD
Vorinostat—Headache—Irinotecan—pancreatic cancer	0.000355	0.00112	CcSEcCtD
Vorinostat—Vomiting—Gemcitabine—pancreatic cancer	0.000351	0.0011	CcSEcCtD
Vorinostat—Headache—Gemcitabine—pancreatic cancer	0.000346	0.00109	CcSEcCtD
Vorinostat—Vomiting—Fluorouracil—pancreatic cancer	0.000345	0.00109	CcSEcCtD
Vorinostat—Decreased appetite—Docetaxel—pancreatic cancer	0.000341	0.00107	CcSEcCtD
Vorinostat—Headache—Fluorouracil—pancreatic cancer	0.00034	0.00107	CcSEcCtD
Vorinostat—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000339	0.00107	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000338	0.00106	CcSEcCtD
Vorinostat—Fatigue—Docetaxel—pancreatic cancer	0.000338	0.00106	CcSEcCtD
Vorinostat—Nausea—Irinotecan—pancreatic cancer	0.000337	0.00106	CcSEcCtD
Vorinostat—Constipation—Docetaxel—pancreatic cancer	0.000335	0.00105	CcSEcCtD
Vorinostat—Chills—Epirubicin—pancreatic cancer	0.000334	0.00105	CcSEcCtD
Vorinostat—Alopecia—Epirubicin—pancreatic cancer	0.000329	0.00103	CcSEcCtD
Vorinostat—Nausea—Gemcitabine—pancreatic cancer	0.000328	0.00103	CcSEcCtD
Vorinostat—Nausea—Fluorouracil—pancreatic cancer	0.000323	0.00101	CcSEcCtD
Vorinostat—Dysgeusia—Epirubicin—pancreatic cancer	0.000317	0.000998	CcSEcCtD
Vorinostat—Muscle spasms—Epirubicin—pancreatic cancer	0.000311	0.00098	CcSEcCtD
Vorinostat—Body temperature increased—Docetaxel—pancreatic cancer	0.00031	0.000975	CcSEcCtD
Vorinostat—Chills—Doxorubicin—pancreatic cancer	0.000309	0.000972	CcSEcCtD
Vorinostat—Alopecia—Doxorubicin—pancreatic cancer	0.000304	0.000957	CcSEcCtD
Vorinostat—Anaemia—Epirubicin—pancreatic cancer	0.000299	0.000942	CcSEcCtD
Vorinostat—Dysgeusia—Doxorubicin—pancreatic cancer	0.000294	0.000924	CcSEcCtD
Vorinostat—Syncope—Epirubicin—pancreatic cancer	0.000291	0.000914	CcSEcCtD
Vorinostat—Leukopenia—Epirubicin—pancreatic cancer	0.00029	0.000912	CcSEcCtD
Vorinostat—Muscle spasms—Doxorubicin—pancreatic cancer	0.000288	0.000907	CcSEcCtD
Vorinostat—Loss of consciousness—Epirubicin—pancreatic cancer	0.000285	0.000896	CcSEcCtD
Vorinostat—Cough—Epirubicin—pancreatic cancer	0.000283	0.000889	CcSEcCtD
Vorinostat—Asthenia—Docetaxel—pancreatic cancer	0.000281	0.000885	CcSEcCtD
Vorinostat—Pruritus—Docetaxel—pancreatic cancer	0.000277	0.000873	CcSEcCtD
Vorinostat—Anaemia—Doxorubicin—pancreatic cancer	0.000277	0.000872	CcSEcCtD
Vorinostat—Chest pain—Epirubicin—pancreatic cancer	0.000276	0.000868	CcSEcCtD
Vorinostat—Dry mouth—Epirubicin—pancreatic cancer	0.00027	0.000849	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—pancreatic cancer	0.000269	0.000846	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—pancreatic cancer	0.000268	0.000844	CcSEcCtD
Vorinostat—Diarrhoea—Docetaxel—pancreatic cancer	0.000268	0.000844	CcSEcCtD
Vorinostat—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000263	0.000829	CcSEcCtD
Vorinostat—Infection—Epirubicin—pancreatic cancer	0.000263	0.000826	CcSEcCtD
Vorinostat—Cough—Doxorubicin—pancreatic cancer	0.000262	0.000823	CcSEcCtD
Vorinostat—Shock—Epirubicin—pancreatic cancer	0.00026	0.000818	CcSEcCtD
Vorinostat—Dizziness—Docetaxel—pancreatic cancer	0.000259	0.000816	CcSEcCtD
Vorinostat—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000259	0.000814	CcSEcCtD
Vorinostat—Chest pain—Doxorubicin—pancreatic cancer	0.000255	0.000803	CcSEcCtD
Vorinostat—Anorexia—Epirubicin—pancreatic cancer	0.000252	0.000793	CcSEcCtD
Vorinostat—Dry mouth—Doxorubicin—pancreatic cancer	0.00025	0.000785	CcSEcCtD
Vorinostat—Vomiting—Docetaxel—pancreatic cancer	0.000249	0.000784	CcSEcCtD
Vorinostat—Headache—Docetaxel—pancreatic cancer	0.000246	0.000773	CcSEcCtD
Vorinostat—Infection—Doxorubicin—pancreatic cancer	0.000243	0.000765	CcSEcCtD
Vorinostat—Shock—Doxorubicin—pancreatic cancer	0.000241	0.000757	CcSEcCtD
Vorinostat—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.00024	0.000754	CcSEcCtD
Vorinostat—Anorexia—Doxorubicin—pancreatic cancer	0.000233	0.000734	CcSEcCtD
Vorinostat—Nausea—Docetaxel—pancreatic cancer	0.000233	0.000733	CcSEcCtD
Vorinostat—Decreased appetite—Epirubicin—pancreatic cancer	0.00023	0.000723	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000228	0.000718	CcSEcCtD
Vorinostat—Fatigue—Epirubicin—pancreatic cancer	0.000228	0.000717	CcSEcCtD
Vorinostat—Constipation—Epirubicin—pancreatic cancer	0.000226	0.000711	CcSEcCtD
Vorinostat—Decreased appetite—Doxorubicin—pancreatic cancer	0.000213	0.000669	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000211	0.000664	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—pancreatic cancer	0.000211	0.000664	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—pancreatic cancer	0.000209	0.000658	CcSEcCtD
Vorinostat—Body temperature increased—Epirubicin—pancreatic cancer	0.000209	0.000658	CcSEcCtD
Vorinostat—Body temperature increased—Doxorubicin—pancreatic cancer	0.000193	0.000608	CcSEcCtD
Vorinostat—Asthenia—Epirubicin—pancreatic cancer	0.00019	0.000597	CcSEcCtD
Vorinostat—Pruritus—Epirubicin—pancreatic cancer	0.000187	0.000589	CcSEcCtD
Vorinostat—Diarrhoea—Epirubicin—pancreatic cancer	0.000181	0.000569	CcSEcCtD
Vorinostat—Asthenia—Doxorubicin—pancreatic cancer	0.000176	0.000552	CcSEcCtD
Vorinostat—Dizziness—Epirubicin—pancreatic cancer	0.000175	0.00055	CcSEcCtD
Vorinostat—Pruritus—Doxorubicin—pancreatic cancer	0.000173	0.000545	CcSEcCtD
Vorinostat—Vomiting—Epirubicin—pancreatic cancer	0.000168	0.000529	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—pancreatic cancer	0.000167	0.000527	CcSEcCtD
Vorinostat—Headache—Epirubicin—pancreatic cancer	0.000166	0.000521	CcSEcCtD
Vorinostat—Dizziness—Doxorubicin—pancreatic cancer	0.000162	0.000509	CcSEcCtD
Vorinostat—Nausea—Epirubicin—pancreatic cancer	0.000157	0.000494	CcSEcCtD
Vorinostat—Vomiting—Doxorubicin—pancreatic cancer	0.000156	0.000489	CcSEcCtD
Vorinostat—Headache—Doxorubicin—pancreatic cancer	0.000153	0.000482	CcSEcCtD
Vorinostat—Nausea—Doxorubicin—pancreatic cancer	0.000145	0.000457	CcSEcCtD
Vorinostat—HDAC3—Disease—STAT3—pancreatic cancer	2.04e-05	3.45e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—STAT3—pancreatic cancer	2.03e-05	3.45e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—NRAS—pancreatic cancer	2.03e-05	3.44e-05	CbGpPWpGaD
Vorinostat—HDAC1—Hemostasis—AKT1—pancreatic cancer	2.03e-05	3.44e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—NRAS—pancreatic cancer	2.03e-05	3.44e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CB—pancreatic cancer	2.03e-05	3.44e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CNR1—pancreatic cancer	2.03e-05	3.44e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—NRAS—pancreatic cancer	2.03e-05	3.43e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CASP3—pancreatic cancer	2.02e-05	3.43e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTGS2—pancreatic cancer	2.01e-05	3.41e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APOE—pancreatic cancer	2e-05	3.39e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CXCL8—pancreatic cancer	1.98e-05	3.35e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CB—pancreatic cancer	1.98e-05	3.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TERT—pancreatic cancer	1.97e-05	3.34e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCND1—pancreatic cancer	1.97e-05	3.33e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—GCG—pancreatic cancer	1.96e-05	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KDR—pancreatic cancer	1.96e-05	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTGS2—pancreatic cancer	1.96e-05	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CTNNB1—pancreatic cancer	1.95e-05	3.3e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—KRAS—pancreatic cancer	1.95e-05	3.3e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CD—pancreatic cancer	1.95e-05	3.3e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—SRC—pancreatic cancer	1.94e-05	3.29e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HRAS—pancreatic cancer	1.92e-05	3.25e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—PIK3CA—pancreatic cancer	1.92e-05	3.25e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PIK3CA—pancreatic cancer	1.91e-05	3.24e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MMP9—pancreatic cancer	1.91e-05	3.24e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—SRC—pancreatic cancer	1.91e-05	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PTEN—pancreatic cancer	1.91e-05	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PTEN—pancreatic cancer	1.9e-05	3.22e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MYC—pancreatic cancer	1.89e-05	3.21e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MYC—pancreatic cancer	1.89e-05	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CASP3—pancreatic cancer	1.89e-05	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—TGFB1—pancreatic cancer	1.89e-05	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TGFB1—pancreatic cancer	1.89e-05	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HIF1A—pancreatic cancer	1.89e-05	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TGFB1—pancreatic cancer	1.88e-05	3.19e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TSC2—pancreatic cancer	1.88e-05	3.19e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MYC—pancreatic cancer	1.87e-05	3.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—STAT3—pancreatic cancer	1.87e-05	3.17e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—AKT1—pancreatic cancer	1.87e-05	3.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AGTR1—pancreatic cancer	1.87e-05	3.17e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—NRAS—pancreatic cancer	1.87e-05	3.17e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NFKBIA—pancreatic cancer	1.86e-05	3.16e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—pancreatic cancer	1.86e-05	3.15e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—pancreatic cancer	1.85e-05	3.14e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EGFR—pancreatic cancer	1.85e-05	3.14e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EGFR—pancreatic cancer	1.85e-05	3.13e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CB—pancreatic cancer	1.85e-05	3.13e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOTCH1—pancreatic cancer	1.85e-05	3.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STK11—pancreatic cancer	1.84e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APOE—pancreatic cancer	1.84e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCND1—pancreatic cancer	1.84e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—STAT3—pancreatic cancer	1.84e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—NRAS—pancreatic cancer	1.84e-05	3.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—NOTCH1—pancreatic cancer	1.83e-05	3.1e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CTNNB1—pancreatic cancer	1.82e-05	3.09e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CG—pancreatic cancer	1.81e-05	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PIK3CA—pancreatic cancer	1.79e-05	3.03e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MMP9—pancreatic cancer	1.79e-05	3.03e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGF—pancreatic cancer	1.78e-05	3.02e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PTEN—pancreatic cancer	1.78e-05	3.01e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CXCL8—pancreatic cancer	1.77e-05	3.01e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—HRAS—pancreatic cancer	1.77e-05	3e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HRAS—pancreatic cancer	1.77e-05	3e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—SRC—pancreatic cancer	1.76e-05	2.98e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTEN—pancreatic cancer	1.75e-05	2.97e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CTNNB1—pancreatic cancer	1.75e-05	2.97e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KRAS—pancreatic cancer	1.75e-05	2.96e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KRAS—pancreatic cancer	1.75e-05	2.96e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—KRAS—pancreatic cancer	1.74e-05	2.96e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MYC—pancreatic cancer	1.74e-05	2.95e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—TGFB1—pancreatic cancer	1.74e-05	2.94e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—PPARG—pancreatic cancer	1.73e-05	2.93e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—pancreatic cancer	1.72e-05	2.91e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—pancreatic cancer	1.71e-05	2.9e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTEN—pancreatic cancer	1.71e-05	2.89e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TGFB1—pancreatic cancer	1.71e-05	2.89e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—pancreatic cancer	1.7e-05	2.88e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOTCH1—pancreatic cancer	1.7e-05	2.88e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—STAT3—pancreatic cancer	1.7e-05	2.88e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CASP3—pancreatic cancer	1.7e-05	2.88e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CB—pancreatic cancer	1.7e-05	2.88e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—NRAS—pancreatic cancer	1.69e-05	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—AKT1—pancreatic cancer	1.69e-05	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—pancreatic cancer	1.67e-05	2.83e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HRAS—pancreatic cancer	1.66e-05	2.81e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—pancreatic cancer	1.65e-05	2.8e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—SRC—pancreatic cancer	1.65e-05	2.79e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGF—pancreatic cancer	1.64e-05	2.78e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CTNNB1—pancreatic cancer	1.64e-05	2.77e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CXCL8—pancreatic cancer	1.63e-05	2.76e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SMAD4—pancreatic cancer	1.61e-05	2.73e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—pancreatic cancer	1.61e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PIK3CA—pancreatic cancer	1.61e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CA—pancreatic cancer	1.61e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MMP9—pancreatic cancer	1.6e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—pancreatic cancer	1.6e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CA—pancreatic cancer	1.6e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PTEN—pancreatic cancer	1.6e-05	2.7e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—STAT3—pancreatic cancer	1.59e-05	2.69e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CD—pancreatic cancer	1.59e-05	2.69e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—NRAS—pancreatic cancer	1.58e-05	2.69e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—SRC—pancreatic cancer	1.58e-05	2.68e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—pancreatic cancer	1.58e-05	2.68e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—pancreatic cancer	1.58e-05	2.67e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HES1—pancreatic cancer	1.58e-05	2.67e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TGFB1—pancreatic cancer	1.57e-05	2.67e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—AKT1—pancreatic cancer	1.56e-05	2.65e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—AKT1—pancreatic cancer	1.56e-05	2.65e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CASP3—pancreatic cancer	1.56e-05	2.64e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—pancreatic cancer	1.55e-05	2.63e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—pancreatic cancer	1.55e-05	2.63e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—pancreatic cancer	1.54e-05	2.62e-05	CbGpPWpGaD
Vorinostat—NR0B1—Gene Expression—AKT1—pancreatic cancer	1.53e-05	2.59e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—pancreatic cancer	1.53e-05	2.59e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—STAT3—pancreatic cancer	1.53e-05	2.59e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—NRAS—pancreatic cancer	1.52e-05	2.58e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—pancreatic cancer	1.52e-05	2.57e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CTNNB1—pancreatic cancer	1.5e-05	2.55e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HRAS—pancreatic cancer	1.49e-05	2.52e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—HRAS—pancreatic cancer	1.48e-05	2.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—HRAS—pancreatic cancer	1.48e-05	2.51e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—SRC—pancreatic cancer	1.48e-05	2.51e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PIK3CA—pancreatic cancer	1.48e-05	2.5e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—pancreatic cancer	1.48e-05	2.5e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MMP9—pancreatic cancer	1.47e-05	2.5e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TGFB1—pancreatic cancer	1.47e-05	2.5e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PTEN—pancreatic cancer	1.47e-05	2.48e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—AKT1—pancreatic cancer	1.46e-05	2.48e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CD—pancreatic cancer	1.46e-05	2.47e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—pancreatic cancer	1.46e-05	2.47e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CA—pancreatic cancer	1.45e-05	2.46e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—pancreatic cancer	1.44e-05	2.45e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—pancreatic cancer	1.44e-05	2.44e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—STAT3—pancreatic cancer	1.43e-05	2.42e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NRAS—pancreatic cancer	1.42e-05	2.41e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—pancreatic cancer	1.42e-05	2.4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—TGFB1—pancreatic cancer	1.41e-05	2.4e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—pancreatic cancer	1.4e-05	2.38e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—pancreatic cancer	1.39e-05	2.35e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CB—pancreatic cancer	1.38e-05	2.34e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TERT—pancreatic cancer	1.38e-05	2.34e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HRAS—pancreatic cancer	1.37e-05	2.32e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—pancreatic cancer	1.36e-05	2.31e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SRC—pancreatic cancer	1.36e-05	2.3e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CA—pancreatic cancer	1.35e-05	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—HRAS—pancreatic cancer	1.34e-05	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CA—pancreatic cancer	1.34e-05	2.27e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CXCL8—pancreatic cancer	1.33e-05	2.25e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—pancreatic cancer	1.33e-05	2.25e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—pancreatic cancer	1.32e-05	2.24e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TGFB1—pancreatic cancer	1.32e-05	2.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HIF1A—pancreatic cancer	1.32e-05	2.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TSC2—pancreatic cancer	1.32e-05	2.23e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—AKT1—pancreatic cancer	1.31e-05	2.23e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—STAT3—pancreatic cancer	1.31e-05	2.22e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—AKT1—pancreatic cancer	1.31e-05	2.22e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—pancreatic cancer	1.31e-05	2.22e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—AKT1—pancreatic cancer	1.31e-05	2.22e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NRAS—pancreatic cancer	1.31e-05	2.22e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—AKT1—pancreatic cancer	1.3e-05	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—pancreatic cancer	1.3e-05	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—pancreatic cancer	1.3e-05	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APOE—pancreatic cancer	1.29e-05	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CB—pancreatic cancer	1.27e-05	2.16e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CASP3—pancreatic cancer	1.27e-05	2.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KDR—pancreatic cancer	1.26e-05	2.14e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—pancreatic cancer	1.26e-05	2.14e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CA—pancreatic cancer	1.25e-05	2.12e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HRAS—pancreatic cancer	1.24e-05	2.1e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—pancreatic cancer	1.24e-05	2.1e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CA—pancreatic cancer	1.24e-05	2.1e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CTNNB1—pancreatic cancer	1.23e-05	2.08e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—pancreatic cancer	1.23e-05	2.08e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—pancreatic cancer	1.22e-05	2.06e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TGFB1—pancreatic cancer	1.22e-05	2.06e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—pancreatic cancer	1.21e-05	2.05e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—AKT1—pancreatic cancer	1.21e-05	2.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CA—pancreatic cancer	1.2e-05	2.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MMP9—pancreatic cancer	1.2e-05	2.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NFKBIA—pancreatic cancer	1.2e-05	2.04e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PTEN—pancreatic cancer	1.2e-05	2.03e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—pancreatic cancer	1.19e-05	2.02e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOTCH1—pancreatic cancer	1.19e-05	2.02e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—AKT1—pancreatic cancer	1.19e-05	2.01e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CG—pancreatic cancer	1.16e-05	1.97e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HRAS—pancreatic cancer	1.16e-05	1.96e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGF—pancreatic cancer	1.15e-05	1.95e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CTNNB1—pancreatic cancer	1.13e-05	1.91e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—pancreatic cancer	1.13e-05	1.91e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CA—pancreatic cancer	1.13e-05	1.91e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HRAS—pancreatic cancer	1.11e-05	1.89e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SRC—pancreatic cancer	1.11e-05	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTEN—pancreatic cancer	1.1e-05	1.86e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—AKT1—pancreatic cancer	1.1e-05	1.86e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—AKT1—pancreatic cancer	1.09e-05	1.85e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—pancreatic cancer	1.09e-05	1.85e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—pancreatic cancer	1.08e-05	1.83e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—STAT3—pancreatic cancer	1.07e-05	1.81e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NRAS—pancreatic cancer	1.07e-05	1.81e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—AKT1—pancreatic cancer	1.06e-05	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HRAS—pancreatic cancer	1.04e-05	1.76e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CA—pancreatic cancer	1.03e-05	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—AKT1—pancreatic cancer	1.02e-05	1.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CD—pancreatic cancer	1.02e-05	1.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SRC—pancreatic cancer	1.02e-05	1.73e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—AKT1—pancreatic cancer	1.01e-05	1.71e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—pancreatic cancer	1e-05	1.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—pancreatic cancer	9.93e-06	1.68e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TGFB1—pancreatic cancer	9.91e-06	1.68e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—pancreatic cancer	9.84e-06	1.67e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—AKT1—pancreatic cancer	9.84e-06	1.67e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—STAT3—pancreatic cancer	9.84e-06	1.67e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NRAS—pancreatic cancer	9.81e-06	1.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—pancreatic cancer	9.71e-06	1.65e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HRAS—pancreatic cancer	9.57e-06	1.62e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—AKT1—pancreatic cancer	9.19e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—pancreatic cancer	9.18e-06	1.56e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—pancreatic cancer	9.14e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—TGFB1—pancreatic cancer	9.12e-06	1.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—pancreatic cancer	8.94e-06	1.52e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CB—pancreatic cancer	8.91e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCL8—pancreatic cancer	8.56e-06	1.45e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—AKT1—pancreatic cancer	8.45e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—pancreatic cancer	8.45e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CA—pancreatic cancer	8.43e-06	1.43e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CASP3—pancreatic cancer	8.2e-06	1.39e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—pancreatic cancer	8.16e-06	1.38e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—pancreatic cancer	7.98e-06	1.35e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CTNNB1—pancreatic cancer	7.9e-06	1.34e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HRAS—pancreatic cancer	7.8e-06	1.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CA—pancreatic cancer	7.76e-06	1.31e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MMP9—pancreatic cancer	7.75e-06	1.31e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PTEN—pancreatic cancer	7.7e-06	1.31e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HRAS—pancreatic cancer	7.18e-06	1.22e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SRC—pancreatic cancer	7.14e-06	1.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—pancreatic cancer	6.96e-06	1.18e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—AKT1—pancreatic cancer	6.89e-06	1.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STAT3—pancreatic cancer	6.89e-06	1.17e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NRAS—pancreatic cancer	6.87e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—AKT1—pancreatic cancer	6.83e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—pancreatic cancer	6.4e-06	1.08e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TGFB1—pancreatic cancer	6.38e-06	1.08e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—AKT1—pancreatic cancer	6.34e-06	1.07e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—pancreatic cancer	6.26e-06	1.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—pancreatic cancer	5.91e-06	1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CA—pancreatic cancer	5.43e-06	9.21e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—pancreatic cancer	5.26e-06	8.91e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HRAS—pancreatic cancer	5.03e-06	8.52e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—AKT1—pancreatic cancer	4.44e-06	7.52e-06	CbGpPWpGaD
